Clinical Trial

Reduce Inefficiencies in Management of Spasticity

Study acronym: ReIMage
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the effectiveness of a spasticity screener and to determine if the spasticity screener results are useful to healthcare providers and impact clinical decision making
Trial Details
NCT Number NCT07639632
Lead Sponsor The University of Texas Health Science Center, Houston
Collaborators: AbbVie
Conditions Stroke
Enrollment 80 participants
Start Date 2026-06-15
Primary Completion 2029-08-01 (estimated)
Study Completion 2029-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-10